These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19642896)

  • 21. Fas expression and function in normal and malignant breast cell lines.
    Keane MM; Ettenberg SA; Lowrey GA; Russell EK; Lipkowitz S
    Cancer Res; 1996 Oct; 56(20):4791-8. PubMed ID: 8841000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
    Bharhani MS; Borojevic R; Basak S; Ho E; Zhou P; Croitoru K
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G820-9. PubMed ID: 17030898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRF-1-mediated CAS expression enhances interferon-gamma-induced apoptosis of HT-29 colon adenocarcinoma cells.
    Jiang MC; Lin TL; Lee TL; Huang HT; Lin CL; Liao CF
    Mol Cell Biol Res Commun; 2001 Nov; 4(6):353-8. PubMed ID: 11703094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between GAGE-1/-2 expression, EBV infection and interferon-gamma expression in undifferentiated carcinoma of nasopharyngeal type.
    Schlott T; Middel P; Laskawi R; Brinck U; Ruschenburg I; Droese M
    Anticancer Res; 2000; 20(3A):1727-32. PubMed ID: 10928100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma downregulates Hsp27 expression and suppresses the negative regulation of cell death in oral squamous cell carcinoma lines.
    Yonekura N; Yokota S; Yonekura K; Dehari H; Arata S; Kohama G; Fujii N
    Cell Death Differ; 2003 Mar; 10(3):313-22. PubMed ID: 12700631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAT1/IRF-1 signaling pathway mediates the injurious effect of interferon-gamma on oligodendrocyte progenitor cells.
    Wang Y; Ren Z; Tao D; Tilwalli S; Goswami R; Balabanov R
    Glia; 2010 Jan; 58(2):195-208. PubMed ID: 19606498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant potential of H22 hepatocarcinoma cells increases after recovery from IFN-γ-mediated inhibition.
    Gong W; Ma KZ; Liang X; Liu Y; Zhou Q; Zhang J; Chen H; Liu WW
    Cell Biol Int; 2011 Jul; 35(7):747-54. PubMed ID: 21261597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression.
    Xu X; Fu XY; Plate J; Chong AS
    Cancer Res; 1998 Jul; 58(13):2832-7. PubMed ID: 9661898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT1-mediated down-regulation of Bcl-2 expression is involved in IFN-γ/TNF-α-induced apoptosis in NIT-1 cells.
    Cao ZH; Zheng QY; Li GQ; Hu XB; Feng SL; Xu GL; Zhang KQ
    PLoS One; 2015; 10(3):e0120921. PubMed ID: 25811609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes.
    Kano A; Haruyama T; Akaike T; Watanabe Y
    Biochem Biophys Res Commun; 1999 Apr; 257(3):672-7. PubMed ID: 10208842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of IFN-γ-induced B7-H1 expression by 15-deoxy-delta(12,14)-prostaglandin J2 via downregulation of the Jak/STAT/IRF-1 signaling pathway.
    Seo SK; Seo DI; Park WS; Jung WK; Lee DS; Park SG; Choi JS; Kang MS; Choi YH; Choi I; Yu BC; Choi IW
    Life Sci; 2014 Sep; 112(1-2):82-9. PubMed ID: 25072357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa.
    Nozawa Y; Van Belzen N; Van der Made AC; Dinjens WN; Bosman FT
    J Pathol; 1996 Jan; 178(1):48-52. PubMed ID: 8778315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IFN-gamma inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-gamma-enhanced TRAIL-induced apoptosis.
    Park SY; Billiar TR; Seol DW
    Biochem Biophys Res Commun; 2002 Feb; 291(2):233-6. PubMed ID: 11846395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of nucleophosmin/B23 mRNA delays the entry of cells into mitosis.
    Jiang PS; Yung BY
    Biochem Biophys Res Commun; 1999 Apr; 257(3):865-70. PubMed ID: 10208875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
    Chaturvedi V; Bodner B; Qin JZ; Nickoloff BJ
    J Dermatol Sci; 2006 Jan; 41(1):31-41. PubMed ID: 16289694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors.
    Sjöstrand M; Ambrosi A; Brauner S; Sullivan J; Malin S; Kuchroo VK; Espinosa A; Wahren-Herlenius M
    J Immunol; 2013 Oct; 191(7):3753-63. PubMed ID: 23975864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells.
    AbuSara N; Razavi S; Derwish L; Komatsu Y; Licursi M; Hirasawa K
    Cancer Lett; 2015 Feb; 357(2):575-81. PubMed ID: 25497010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program.
    Negishi H; Fujita Y; Yanai H; Sakaguchi S; Ouyang X; Shinohara M; Takayanagi H; Ohba Y; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15136-41. PubMed ID: 17018642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion of Fas-resistant to Fas-sensitive MCF-7 breast cancer cells by the synergistic interaction of interferon-gamma and all-trans retinoic acid.
    Danforth DN; Zhu Y
    Breast Cancer Res Treat; 2005 Nov; 94(1):81-91. PubMed ID: 16136269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Batf2/Irf1 induces inflammatory responses in classically activated macrophages, lipopolysaccharides, and mycobacterial infection.
    Roy S; Guler R; Parihar SP; Schmeier S; Kaczkowski B; Nishimura H; Shin JW; Negishi Y; Ozturk M; Hurdayal R; Kubosaki A; Kimura Y; de Hoon MJ; Hayashizaki Y; Brombacher F; Suzuki H
    J Immunol; 2015 Jun; 194(12):6035-44. PubMed ID: 25957166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.